Infectious Disease Diagnostic Test
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Global Market Study on Electronic<br />
Cylinder Lock Credentials: Europe to<br />
Remain Largest Market with Near<br />
30% Share 2016–2024
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
About Us<br />
Persistence Market Research (PMR) is a market intelligence company, providing global business<br />
information reports and services. Our exclusive blend of quantitative forecasting and trends analysis<br />
provides forward-looking insight for thousands of decision makers. We have an experienced team of<br />
Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and<br />
techniques to gather, and analyze information. Our business offerings represent the latest and the most<br />
reliable information indispensable for businesses to sustain a competitive edge.<br />
Each PMR Syndicated Research report covers a different sector - such as pharmaceuticals, chemical,<br />
energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports<br />
provide in-depth analysis and deep segmentation to possible micro levels. With a wider scope and stratified<br />
research methodology, our syndicated reports strive to serve clients and satisfy their overall research<br />
requirement.<br />
Copyright © 2015 Persistence Market Research<br />
All Rights Reserved. This document contains highly confidential information and is the sole property of<br />
PMR. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of<br />
PMR.<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 2
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Report Media Releases<br />
Global Demand for <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong> <strong>Test</strong> Kits to Reach<br />
US$ 876.8 Mn in 2016, with APAC Expected to Emerge the Most<br />
Lucrative Market over the Forecast Period<br />
According to the latest market report published by Persistence Market Research, titled “Global Market<br />
Study on <strong>Infectious</strong> <strong>Disease</strong>s <strong>Diagnostic</strong>s: Increasing Demand for Evidence-Based Treatment to<br />
Boost Demand for <strong>Infectious</strong> <strong>Diagnostic</strong> <strong>Test</strong>ing during Forecast Period”. The global market for<br />
infectious diseases diagnostics is estimated to reach US$ 876.6 Mn in 2016 from US$ 827.7 Mn in 2015<br />
owing to increasing demand for diagnostic kits caused by rising incidence rate of infectious diseases.<br />
The global infectious disease diagnostics market is expected to reach US$ 1503.8 Mn by 2024. Sexually<br />
Transmitted <strong>Disease</strong>s (STDs) segment is expected to continue to remain the largest segment by diseases<br />
indication accounting for US$ 282.4 Mn in terms of revenue in 2016, a Y – o – Y increase of 7.0% over<br />
2015. The chlamydia diagnostics test kits are expected to gain upward momentum in 2016, growing at<br />
8.9% in terms of revenue, the fastest among disease indication segment.<br />
Cell cultures segment is expected to register highest CAGR in terms of revenue, by test type accounting for<br />
US$ 311.4 Mn in terms of revenue in 2016. The affordability of cell culture kits and large applications in<br />
diagnosis of several infectious diseases is gaining traction. Consumption demand for cell culture test kits<br />
will witness a growth rate of 7.2 % in 2016 over 2015.<br />
<strong>Diagnostic</strong> centers end user segment is expected to register highest CAGR in terms of revenue,<br />
accounting for US$ 392.8 Mn in terms of revenue in 2016. The increasing number of diagnostics centers,<br />
worldwide and a large number of patient pool depending on diagnostics centers for diagnosis of infectious<br />
diseases is expected to increase demand for diagnostics tests among diagnostics centers. The diagnostics<br />
centers end user segment will witness a growth rate of 7.4 % in 2016 over 2015.<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 3
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Becton, Dickinson and Company, Cepheid, Inc. Abbott Laboratories, bioMérieux SA, Hologic, Inc., Danaher<br />
Corporation, Thermo Fisher Scientific Inc., Roche <strong>Diagnostic</strong>s, Alere Inc., DiaSorin S.p.A., Quidel<br />
Corporation, and Bio-Rad Laboratories, Inc. are key players in the market. Top players are focusing on<br />
developing new products and improving sensitivity and specificity of the test kits. Collaborations and joint<br />
ventures among manufacturers and local governments are key business strategies being adopted to<br />
increase market share.<br />
PMR Long-term Outlook: PMR projects the global infectious disease diagnostics market to witness<br />
moderate growth during the forecast period 2016–2024. APAC will continue to remain the largest market for<br />
infectious disease diagnostics, registering a CAGR of 7.9% over the forecast period.<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 4
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Report TOC<br />
<strong>Infectious</strong> <strong>Disease</strong>s <strong>Diagnostic</strong>s Market : TOC<br />
Home Life Sciences & Transformational Health <strong>Infectious</strong> <strong>Disease</strong>s <strong>Diagnostic</strong>s<br />
Market Table of Content<br />
Browse & Free Download - Table of Content<br />
Full Name*: Email Id*: Company Name* : Job Title* : Phone No* : Captcha* :<br />
628 I accept Privacy Policy Submit Request<br />
Report code : PMRREP11413 | Industry : Life Sciences & Transformational Health |<br />
Published On : Aug-2016 | Pages : 241 Pages | Format :<br />
Table Of Content<br />
1. Executive Summary<br />
2. Assumptions and Acronyms<br />
3. Research Methodology<br />
4. <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Overview<br />
4.1. Introduction<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 5
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
4.1.1. <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Definition<br />
4.1.2. <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Taxonomy<br />
4.2. <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Dynamics<br />
4.2.1. Drivers<br />
4.2.2. Restraints<br />
4.2.3. Opportunities<br />
4.2.4. Trends<br />
5. Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Analysis, By <strong>Disease</strong> Indication<br />
5.1. Introduction<br />
5.1.1. Y-o-Y Growth Comparison, By <strong>Disease</strong> Indication<br />
5.1.2. Market Share & Basis Point (BPS) Analysis, By <strong>Disease</strong> Indication<br />
5.2. Market Forecast, By <strong>Disease</strong> Indication<br />
5.2.1. CNS Infection<br />
5.2.1.1. Absolute $ Opportunity<br />
5.2.1.2. Market Value (US$ Mn) Forecast<br />
5.2.1.3. Meningitis<br />
5.2.1.4. Brain Abscess<br />
5.2.2. Diarrheal <strong>Disease</strong>s<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 6
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
5.2.2.1. Absolute $ Opportunity<br />
5.2.2.2. Market Value (US$ Mn) Forecast<br />
5.2.2.3. Shigellosis<br />
5.2.2.4. Cholera<br />
5.2.2.5. Enteric/Typhoid Fever<br />
5.2.3. Respiratory Infections<br />
5.2.3.1. Absolute $ Opportunity<br />
5.2.3.2. Market Value (US$ Mn) Forecast<br />
5.2.3.3. Tuberculosis<br />
5.2.3.4. Influenza<br />
5.2.3.5. Bronchitis<br />
5.2.4. Blood Infections<br />
5.2.4.1. Absolute $ Opportunity<br />
5.2.4.2. Market Value (US$ Mn) Forecast<br />
5.2.4.3. Malaria<br />
5.2.4.4. Dengue<br />
5.2.4.5. <strong>Infectious</strong> Mononucleosis<br />
5.2.4.6. Others<br />
5.2.5. Sexually Transmitted <strong>Disease</strong>s<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 7
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
5.2.5.1. Absolute $ Opportunity<br />
5.2.5.2. Market Value (US$ Mn) Forecast<br />
5.2.5.3. Chlamydia<br />
5.2.5.4. AIDS<br />
5.2.5.5. Syphilis<br />
5.2.5.6. Others<br />
5.3. Market Attractiveness Analysis, By <strong>Disease</strong> Indication<br />
6. Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Analysis, By Technique<br />
6.1. Introduction<br />
6.1.1. Y-o-Y Growth Comparison, By Technique<br />
6.1.2. Market Share & Basis Point (BPS) Analysis, By Technique<br />
6.2. Market Forecast, By Technique<br />
6.2.1. ELISA<br />
6.2.1.1. Absolute $ Opportunity<br />
6.2.1.2. Market Value (US$ Mn) Forecast<br />
6.2.2. Polymerase Chain Reaction<br />
6.2.2.1. Absolute $ Opportunity<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 8
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
6.2.2.2. Market Value (US$ Mn) Forecast<br />
6.2.3. Immunoassays<br />
6.2.3.1. Absolute $ Opportunity<br />
6.2.3.2. Market Value (US$ Mn) Forecast<br />
6.2.4. Cell Cultures<br />
6.2.4.1. Absolute $ Opportunity<br />
6.2.4.2. Market Value (US$ Mn) Forecast<br />
6.2.5. Others<br />
6.2.5.1. Absolute $ Opportunity<br />
6.2.5.2. Market Value (US$ Mn) Forecast<br />
6.3. Market Attractiveness Analysis, By Technique<br />
7. Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Analysis, By End User<br />
7.1. Introduction<br />
7.1.1. Y-o-Y Growth Comparison, By End User<br />
7.1.2. Market Share & Basis Point (BPS) Analysis, By End User<br />
7.2. Market Forecast, By End User<br />
7.2.1. Hospitals<br />
7.2.1.1. Absolute $ Opportunity<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 9
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
7.2.1.2. Market Value (US$ Mn) Forecast<br />
7.2.2. <strong>Diagnostic</strong> Centers<br />
7.2.2.1. Absolute $ Opportunity<br />
7.2.2.2. Market Value (US$ Mn) Forecast<br />
7.2.3. Clinics<br />
7.2.3.1. Absolute $ Opportunity<br />
7.2.3.2. Market Value (US$ Mn) Forecast<br />
7.2.4. Government Organisations<br />
7.2.4.1. Absolute $ Opportunity<br />
7.2.4.2. Market Value (US$ Mn) Forecast<br />
7.3. Market Attractiveness Analysis, By End User<br />
8. Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Analysis, By Region<br />
8.1. Introduction<br />
8.1.1. Y-o-Y Growth Projections, By Region<br />
8.1.2. Market Share & Basis Point (BPS) Analysis, By Region<br />
8.2. Market Forecast, By Region<br />
8.2.1. North America Market Value (US$ Mn) Forecast<br />
8.2.2. Latin America Market Value (US$ Mn) Forecast<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 10
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
8.2.3. Europe Market Value (US$ Mn) Forecast<br />
8.2.4. APAC Market Value (US$ Mn) Forecast<br />
8.2.5. MEA Market Value (US$ Mn) Forecast<br />
8.3. Regional Attractiveness Analysis<br />
9. North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Analysis<br />
9.1. Introduction<br />
9.1.1. Y-o-Y Growth Projections, By Country<br />
9.1.2. Market Share & Basis Point (BPS) Analysis, By Country<br />
9.2. Key Trends<br />
9.3. North America Market Forecast<br />
9.3.1. Market Value (US$ Mn) Forecast, By Country<br />
9.3.1.1. U.S. Absolute $ Opportunity<br />
9.3.1.2. Canada Absolute $ Opportunity<br />
9.3.2. Market Value (US$ Mn) Forecast, By <strong>Disease</strong> Indication<br />
9.3.2.1. CNS Infection<br />
9.3.2.1.1. Meningitis<br />
9.3.2.1.2. Brain Abscess<br />
9.3.2.2. Diarrheal <strong>Disease</strong>s<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 11
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
9.3.2.2.1. Shigellosis<br />
9.3.2.2.2. Cholera<br />
9.3.2.2.3. Typhoid Fever<br />
9.3.2.3. Respiratory Infections<br />
9.3.2.3.1. Tuberculosis<br />
9.3.2.3.2. Influenza<br />
9.3.2.3.3. Bronchitis<br />
9.3.2.4. Blood Infections<br />
9.3.2.4.1. Malaria<br />
9.3.2.4.2. Dengue<br />
9.3.2.4.3. <strong>Infectious</strong> Mononucleosis<br />
9.3.2.4.4. Others<br />
9.3.2.5. Sexually Transmitted <strong>Disease</strong>s<br />
9.3.2.5.1. Chlamydia<br />
9.3.2.5.2. AIDS<br />
9.3.2.5.3. Syphilis<br />
9.3.2.5.4. Others<br />
9.3.3. Market Value (US$ Mn) Forecast, By End User<br />
9.3.3.1. Hospitals<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 12
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
9.3.3.2. <strong>Diagnostic</strong> Centers<br />
9.3.3.3. Clinics<br />
9.3.3.3. Government Organisations<br />
9.3.4. Market Value (US$ Mn) Forecast, By Technique<br />
9.3.4.1. ELISA<br />
9.3.4.2. Polymerase Chain Reaction<br />
9.3.4.3. Immunoassays<br />
9.3.4.4. Cell Cultures<br />
9.3.4.5. Others<br />
9.4. Market Attractiveness Analysis<br />
9.4.1. By Country<br />
9.4.2. By <strong>Disease</strong> Indication<br />
9.4.3. By Technique<br />
9.4.4. By End User<br />
10. Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Analysis<br />
10.1. Introduction<br />
10.1.1. Y-o-Y Growth Projections, By Country<br />
10.1.2. Market Share & Basis Point (BPS) Analysis, By Country<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 13
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
10.2. Key Trends<br />
10.3. Latin America Market Forecast<br />
10.3.1. Market Value (US$ Mn) Forecast, By Country<br />
10.3.1.1. Brazil Absolute $ Opportunity<br />
10.3.1.2. Mexico Absolute $ Opportunity<br />
10.3.1.3. Rest of Latin America Absolute $ Opportunity<br />
10.3.2. Market Value (US$ Mn) Forecast, By <strong>Disease</strong> Indication<br />
10.3.2.1. CNS Infection<br />
10.3.2.1.1. Meningitis<br />
10.3.2.1.2. Brain Abscess<br />
10.3.2.2. Diarrheal <strong>Disease</strong>s<br />
10.3.2.2.1. Shigellosis<br />
10.3.2.2.2. Cholera<br />
10.3.2.2.3. Typhoid Fever<br />
10.3.2.3. Respiratory Infections<br />
10.3.2.3.1. Tuberculosis<br />
10.3.2.3.2. Influenza<br />
10.3.2.3.3. Bronchitis<br />
10.3.2.4. Blood Infections<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 14
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
10.3.2.4.1. Malaria<br />
10.3.2.4.2. Dengue<br />
10.3.2.4.3. <strong>Infectious</strong> Mononucleosis<br />
10.3.2.4.4. Others<br />
10.3.2.5. Sexually Transmitted <strong>Disease</strong>s<br />
10.3.2.5.1. Chlamydia<br />
10.3.2.5.2. AIDS<br />
10.3.2.5.3. Syphilis<br />
10.3.2.5.4. Others<br />
10.3.3. Market Value (US$ Mn) Forecast, By End User<br />
10.3.3.1. Hospitals<br />
10.3.3.2. <strong>Diagnostic</strong> Centers<br />
10.3.3.3. Clinics<br />
10.3.3.4. Government Organisations<br />
10.3.4. Market Value (US$ Mn) Forecast, By Technique<br />
10.3.4.1. ELISA<br />
10.3.4.2. Polymerase Chain Reaction<br />
10.3.4.3. Immunoassays<br />
10.3.4.4. Cell Cultures<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 15
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
10.3.4.5. Others<br />
10.4. Market Attractiveness Analysis<br />
10.4.1. By Country<br />
10.4.2. By <strong>Disease</strong> Indication<br />
10.4.3. By Technique<br />
10.4.4. By End User<br />
11. Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Analysis<br />
11.1. Introduction<br />
11.1.1. Y-o-Y Growth Projections, By Country<br />
11.1.2. Market Share & Basis Point (BPS) Analysis, By Country<br />
11.2. Key Trends<br />
11.3. Europe Market Forecast<br />
11.3.1. Market Value (US$ Mn) Forecast, By Country<br />
11.3.1.1. U.K. Absolute $ Opportunity<br />
11.3.1.2. Germany Absolute $ Opportunity<br />
11.3.1.3. Italy Absolute $ Opportunity<br />
11.3.1.4. France Absolute $ Opportunity<br />
11.3.1.5. Spain Absolute $ Opportunity<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 16
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
11.3.1.6. Rest of Europe Absolute $ Opportunity<br />
11.3.2. Market Value (US$ Mn) Forecast, By <strong>Disease</strong> Indication<br />
11.3.2.1. CNS Infection<br />
11.3.2.1.1. Meningitis<br />
11.3.2.1.2. Brain Abscess<br />
11.3.2.2. Diarrheal <strong>Disease</strong>s<br />
11.3.2.2.1. Shigellosis<br />
11.3.2.2.2. Cholera<br />
11.3.2.2.3. Typhoid Fever<br />
11.3.2.3. Respiratory Infections<br />
11.3.2.3.1. Tuberculosis<br />
11.3.2.3.2. Influenza<br />
11.3.2.3.3. Bronchitis<br />
11.3.2.4. Blood Infections<br />
11.3.2.4.1. Malaria<br />
11.3.2.4.2. Dengue<br />
11.3.2.4.3. <strong>Infectious</strong> Mononucleosis<br />
11.3.2.4.4. Others<br />
11.3.2.5. Sexually Transmitted <strong>Disease</strong>s<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 17
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
11.3.2.5.1. Chlamydia<br />
11.3.2.5.2. AIDS<br />
11.3.2.5.3. Syphilis<br />
11.3.2.5.4. Others<br />
11.3.3. Market Value (US$ Mn) Forecast, By End User<br />
11.3.3.1. Hospitals<br />
11.3.3.2. <strong>Diagnostic</strong> Centers<br />
11.3.3.3. Clinics<br />
11.3.3.4. Government Organisations<br />
11.3.4. Market Value (US$ Mn) Forecast, By Technique<br />
11.3.4.1. ELISA<br />
11.3.4.2. Polymerase Chain Reaction<br />
11.3.4.3. Immunoassays<br />
11.3.4.4. Cell Cultures<br />
11.3.4.5. Others<br />
11.4. Market Attractiveness Analysis<br />
11.4.1. By Country<br />
11.4.2. By <strong>Disease</strong> Indication<br />
11.4.3. By Technique<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 18
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
11.4.4. By End User<br />
12. APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Analysis<br />
12.1. Introduction<br />
12.1.1. Y-o-Y Growth Projections, By Country<br />
12.1.2. Market Share & Basis Point (BPS) Analysis, By Country<br />
12.2. Key Trends<br />
12.3. APAC Market Forecast<br />
12.3.1. Market Value (US$ Mn) Forecast, By Country<br />
12.3.1.1. China Absolute $ Opportunity<br />
12.3.1.2. India Absolute $ Opportunity<br />
12.3.1.3. Japan Absolute $ Opportunity<br />
12.3.1.4. Australia & New Zealand Absolute $ Opportunity<br />
12.3.1.5. Rest of APAC Absolute $ Opportunity<br />
12.3.2. Market Value (US$ Mn) Forecast, By <strong>Disease</strong> Indication<br />
12.3.2.1. CNS Infection<br />
12.3.2.1.1. Meningitis<br />
12.3.2.1.2. Brain Abscess<br />
12.3.2.2. Diarrheal <strong>Disease</strong>s<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 19
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
12.3.2.2.1. Shigellosis<br />
12.3.2.2.2. Cholera<br />
12.3.2.2.3. Typhoid Fever<br />
12.3.2.3. Respiratory Infections<br />
12.3.2.3.1. Tuberculosis<br />
12.3.2.3.2. Influenza<br />
12.3.2.3.3. Bronchitis<br />
12.3.2.4. Blood Infections<br />
12.3.2.4.1. Malaria<br />
12.3.2.4.2. Dengue<br />
12.3.2.4.3. <strong>Infectious</strong> Mononucleosis<br />
12.3.2.4.4. Others<br />
12.3.2.5. Sexually Transmitted <strong>Disease</strong>s<br />
12.3.2.5.1. Chlamydia<br />
12.4.2.5.2. AIDS<br />
12.4.2.5.3. Syphilis<br />
12.4.2.5.4. Others<br />
12.3.3. Market Value (US$ Mn) Forecast, By End User<br />
12.3.3.1. Hospitals<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 20
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
12.3.3.2. <strong>Diagnostic</strong> Centers<br />
12.3.3.3. Clinics<br />
12.3.3.4. Government Organisations<br />
12.3.4. Market Value (US$ Mn) Forecast, By Technique<br />
12.3.4.1. ELISA<br />
12.3.4.2. Polymerase Chain Reaction<br />
12.3.4.3. Immunoassays<br />
12.3.4.4. Cell Cultures<br />
12.3.4.5. Others<br />
12.4. Market Attractiveness Analysis<br />
12.4.1. By Country<br />
12.4.2. By <strong>Disease</strong> Indication<br />
12.4.3. By Technique<br />
12.4.4. By End User<br />
13. MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Analysis<br />
13.1. Introduction<br />
13.1.1. Y-o-Y Growth Projections, By Country<br />
13.1.2. Market Share & Basis Point (BPS) Analysis, By Country<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 21
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
13.2. Key Trends<br />
13.3. MEA Market Forecast<br />
13.3.1. Market Value (US$ Mn) Forecast, By Country<br />
13.3.2.1. GCC Countries Absolute $ Opportunity<br />
13.3.2.2. South Africa Absolute $ Opportunity<br />
13.3.2.3. Rest of MEA Absolute $ Opportunity<br />
13.3.2. Market Vlue (US$ Mn) Forecast, By <strong>Disease</strong> Indication<br />
13.3.2.1. CNS Infection<br />
13.3.2.1.1. Meningitis<br />
13.3.2.1.2. Brain Abscess<br />
13.3.2.2. Diarrheal <strong>Disease</strong>s<br />
13.3.2.2.1. Shigellosis<br />
13.3.2.2.2. Cholera<br />
13.3.2.2.3. Typhoid Fever<br />
13.3.2.3. Respiratory Infections<br />
13.3.2.3.1 Tuberculosis<br />
13.3.2.3.2. Influenza<br />
13.3.2.3.3. Bronchitis<br />
13.3.2.4. Blood Infections<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 22
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
13.3.2.4.1. Malaria<br />
13.3.2.4.2. Dengue<br />
13.3.2.4.3. <strong>Infectious</strong> Mononucleosis<br />
13.3.2.4.4. Others<br />
13.3.2.5. Sexually Transmitted <strong>Disease</strong>s<br />
13.3.2.5.1. Chlamydia<br />
13.3.2.5.2. AIDS<br />
13.3.2.5.3. Syphilis<br />
13.3.2.5.4. Others<br />
13.3.3. Market Value (US$ Mn) Forecast, By End User<br />
13.3.3.1. Hospitals<br />
13.3.3.2. <strong>Diagnostic</strong> Centers<br />
13.3.3.3. Clinics<br />
13.3.3.4. Government Organisations<br />
13.4.4. Market Value (US$ Mn) Forecast, By<br />
13.4.5. Market Value (US$ Mn) Forecast, By Technique<br />
13.4.5.1. ELISA<br />
13.4.5.2. Polymerase Chain Reaction<br />
13.4.5.3. Immunoassays<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 23
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
13.4.5.4. Cell Cultures<br />
13.4.5.5. Others<br />
13.4. Market Attractiveness Analysis<br />
13.4.1. By Country<br />
13.4.2. By <strong>Disease</strong> Indication<br />
13.4.3. By Technique<br />
13.4.4. By End User<br />
14. Competition Landscape<br />
14.1. Competition Dashboard<br />
14.2. Company Share Analysis<br />
14.3. Company Profiles<br />
14.3.1. Revenue<br />
14.3.2. Products/Brand Offerings<br />
14.3.3. Key developments<br />
14.3.4. SWOT Analysis<br />
14.4. Company Profiled<br />
14.4.1. Becton Dickinson & Company<br />
14.4.2. Cepheid, Inc.<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 24
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
14.4.4. Abbott Laboratories<br />
14.4.4. bioMerieux SA<br />
14.4.5. Hologic, Inc.<br />
14.4.6. Danaher Corporation<br />
14.4.7. Thermo Fisher Scientific, Inc.<br />
14.4.8. Roche <strong>Diagnostic</strong>s<br />
14.4.9. Alera Inc.<br />
14.4.9. DiaSorin S.p.A.<br />
14.4.11. Quidel Corporation<br />
14.4.12. Bio-Rad Laboratories, Inc.<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 25
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
List of Tables<br />
Table 01: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast<br />
By End User, 2016–2024<br />
Table 02: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast<br />
By <strong>Disease</strong> Indication, 2016–2024<br />
Table 03: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast<br />
By CNS Infection <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 04: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast<br />
By Diarrhoeal <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table: 05 Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast<br />
By Respiratory Infections <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 06: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast<br />
By Blood Infections <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 07: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast<br />
By STDs <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 08: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast<br />
By Technique, 2016–2024<br />
Table 09: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast<br />
By Region, 2016–2024<br />
Table 10: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast By Country, 2016–2024<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 26
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Table 11: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast By <strong>Disease</strong> Indication, 2016–2024<br />
Table 12: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast By CNS Infection <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 13: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast By Diarrhoeal <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 14: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast By Respiratory Infections <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 15: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast By Blood Infections <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 16: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast By STDs <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 17: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast By Technique, 2016–2024<br />
Table 18: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast By End User, 2016–2024<br />
Table 19: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast, By Country, 2016–2024<br />
Table 20: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast, By <strong>Disease</strong> Indication, 2016–2024<br />
Table 21: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast, By CNS Infection <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 22: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast, By Diarrhoeal <strong>Disease</strong> Indication Segment, 2016–2024<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 27
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Table 23: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast, By Respiratory Infections <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 24: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast, By Blood Infections <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 25: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast, By STDs <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 26: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast, By Technique, 2016–2024<br />
Table 27: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast, By End User, 2016–2024<br />
Table 28: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast, By Country, 2016–2024<br />
Table 29: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast, By <strong>Disease</strong> Indication, 2016–2024<br />
Table 30: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast, By CNS Infection <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 31: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast, By Diarrhoeal <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 32: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast, By Respiratory Infections <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 33: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast, By Blood Infections <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 34: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast, By STDs <strong>Disease</strong> Indication Segment, 2016–2024<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 28
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Table 35: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast, By Technique, 2016–2024<br />
Table 36: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and<br />
Forecast, By End User, 2016–2024<br />
Table 37: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast,<br />
By Country, 2016–2024<br />
Table 38: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast,<br />
By <strong>Disease</strong> Indication, 2016–2024<br />
Table 39: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast,<br />
By CNS Infection <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 40: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast,<br />
By Diarrhoeal <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 41: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast,<br />
By Respiratory Infections <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 42: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast,<br />
By Blood Infections <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 43: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast,<br />
By STDs <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 44: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast,<br />
By Technique, 2016–2024<br />
Table 45: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast,<br />
By End User, 2016–2024<br />
Table 46: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast,<br />
By Country, 2016–2024<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 29
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Table 47: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast,<br />
By <strong>Disease</strong> Indication, 2016–2024<br />
Table 48: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast,<br />
By CNS Infection <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 49: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast,<br />
By Diarrhoeal <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 50: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast,<br />
By Respiratory Infections <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 51: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast,<br />
By Blood Infections <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 52: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast,<br />
By STDs <strong>Disease</strong> Indication Segment, 2016–2024<br />
Table 53: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast,<br />
By Technique, 2016–2024<br />
Table 54: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and Forecast,<br />
By End User, 2016–2024<br />
List of Figures<br />
Figure 01: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market – Scenario Forecast, 2015–<br />
2024 (US$ Mn)<br />
Figure 02: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Share Analysis (%) By<br />
<strong>Disease</strong> Indication, 2016–2024<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 30
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Figure 03: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Y-o-Y Growth (%) By<br />
<strong>Disease</strong> Indication, 2016–2024<br />
Figure 04: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness Analysis, By<br />
<strong>Disease</strong> Indication, 2016–2024<br />
Figure 05: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$ Mn)<br />
By <strong>Disease</strong> Indication, 2016–2024<br />
Figure 06: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By <strong>Disease</strong> Indication, 2016–2024<br />
Figure 07: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Share Analysis (%) By CNS<br />
Infections, 2016–2024<br />
Figure 08: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Y-o-Y Growth (%) By CNS<br />
Infections, 2016–2024<br />
Figure 09: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness Analysis By<br />
CNS Infection Segment, 2016–2024<br />
Figure 10: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$ Mn)<br />
By CNS Infection Segment, 2016–2024<br />
Figure 11: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By CNS Infection Segment, 2016–2024<br />
Figure 12: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Share Analysis (%) By<br />
Diarrheal Infection Segment, 2016–2024<br />
Figure13: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Y-o-Y Growth (%) By<br />
Diarrheal Infection Segment, 2016–2024<br />
Figure 14: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness Analysis By<br />
Diarrheal Infection Segment, 2016–2024<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 31
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Figure 15: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$ Mn)<br />
By Diarrheal Infection Segment, 2016–2024<br />
Figure 16: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By Diarrheal Infection Segment, 2016–2024<br />
Figure 17: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Share Analysis (%) By<br />
Respiratory Infection Segment, 2016–2024<br />
Figure 18: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Y-o-Y Growth (%) By<br />
Respiratory Infection Segment, 2016–2024<br />
Figure 19: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness Analysis By<br />
Respiratory Infection Segment, 2016–2024<br />
Figure 20: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$ Mn)<br />
By Respiratory Infection Segment, 2016–2024<br />
Figure 21: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By Respiratory Infection Segment, 2016–2024<br />
Figure 22: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Share Analysis (%) By<br />
Blood Infection Segment, 2016–2024<br />
Figure 23: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Y-o-Y Growth (%) By Blood<br />
Infection Segment, 2016–2024<br />
Figure 24: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness Analysis By<br />
Blood Infection Segment, 2016–2024<br />
Figure 25: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$ Mn)<br />
By Blood Infection Segment, 2016–2024<br />
Figure 26: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By Blood Infection Segment, 2016–2024<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 32
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Figure 27: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Share Analysis (%) By STDs<br />
Segment, 2016–2024<br />
Figure 28: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Y-o-Y Growth (%) By STDs<br />
Segment, 2016–2024<br />
Figure 29: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness Analysis By<br />
STDs Segment, 2016–2024<br />
Figure 30: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$ Mn)<br />
By STDs Segment, 2016–2024<br />
Figure 31: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By STDs Segment, 2016–2024<br />
Figure 32: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Share Analysis (%) By<br />
Technique, 2016–2024<br />
Figure 33: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Y-o-Y Growth (%) By<br />
Technique, 2016–2024<br />
Figure 34: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness Analysis<br />
Technique, 2016–2024<br />
Figure 35: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$ Mn)<br />
By Cell Cultures Technique Segment, 2016–2024<br />
Figure 36: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By Cell Cultures Technique Segment, 2016–2024<br />
Figure 37: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$ Mn)<br />
By Immunoassays Technique Segment, 2016–2024<br />
Figure 38: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By Immunoassays Technique Segment, 2016–2024<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 33
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Figure 39: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$ Mn)<br />
By ELISA Technique Segment, 2016–2024<br />
Figure 40: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By ELISA Technique Segment, 2016–2024<br />
Figure 41: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$ Mn)<br />
By PCR Technique Segment, 2016–2024<br />
Figure 42: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By PCR Technique Segment, 2016–2024<br />
Figure 43: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$ Mn)<br />
By Others Technique Segment, 2016–2024<br />
Figure 44: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By Others Technique Segment, 2016–2024<br />
Figure 45: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Share Analysis (%) By End<br />
User, 2016–2024<br />
Figure 46: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Y-o-Y Growth (%) By End<br />
User, 2016–2024<br />
Figure 47: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness Analysis, By<br />
End User, 2016–2024<br />
Figure 48: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$ Mn)<br />
By Hospitals End User Segment, 2016–2024<br />
Figure 49: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By Hospitals End User Segment, 2016–2024<br />
Figure 50: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$ Mn)<br />
By <strong>Diagnostic</strong> Centers End User Segment, 2016–2024<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 34
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Figure 51: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By <strong>Diagnostic</strong> Centers End User Segment, 2016–2024<br />
Figure 52: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$ Mn)<br />
By Clinics End User Segment, 2016–2024<br />
Figure 53: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By Clinics End User Segment, 2016–2024<br />
Figure 54: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$ Mn)<br />
By Government Organizations End User Segment, 2016–2024<br />
Figure 55: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By Government Organizations End User Segment, 2016–2024<br />
Figure 56: <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Value (US$ Mn) and CAGR (%) By<br />
Region, 2015, 2020, and 2024<br />
Figure 57: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Share Analysis (%) By<br />
Region, 2016–2024<br />
Figure 58: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Y-o-Y Growth (%) By<br />
Region, 2016–2024<br />
Figure 59: Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness Analysis By<br />
Region, 2016–2024<br />
Figure 60: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis<br />
(US$ Mn), 2016–2024<br />
Figure 61: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $<br />
Opportunity (US$ Mn), 2016–2024<br />
Figure 62: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis<br />
(US$ Mn), 2016–2024<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 35
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Figure 63: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $<br />
Opportunity (US$ Mn), 2016–2024<br />
Figure 64: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$<br />
Mn), 2016–2024<br />
Figure 65: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn), 2016–2024<br />
Figure 66: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$ Mn),<br />
2016–2024<br />
Figure 67: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity (US$<br />
Mn), 2016–2024<br />
Figure 68: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$ Mn),<br />
2016–2024<br />
Figure 69: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity (US$<br />
Mn), 2016–2024<br />
Figure 70: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Share Analysis (%)<br />
By <strong>Disease</strong> Indication, 2016–2024<br />
Figure 71: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Y-o-Y Growth (%)<br />
By <strong>Disease</strong> Indication, 2016–2024<br />
Figure 72: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Share Analysis (%)<br />
By Country, 2016–2024<br />
Figure 73: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Y-o-Y Growth (%)<br />
By Country, 2016–2024<br />
Figure 74: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis<br />
(US$ Mn) By U.S., 2016–2024<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 36
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Figure 75: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $<br />
Opportunity (US$ Mn) By U.S., 2016–2024<br />
Figure 76: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis<br />
(US$ Mn) By Canada, 2016–2024<br />
Figure 77: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $<br />
Opportunity (US$ Mn) By Canada, 2016–2024<br />
Figure 78: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness<br />
Analysis, By Country, 2016–2024<br />
Figure 79: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness<br />
Analysis, By <strong>Disease</strong> Indication, 2016–2024<br />
Figure 80: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness<br />
Analysis, By Technique, 2016–2024<br />
Figure 81: North America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness<br />
Analysis, By End User, 2016–2024<br />
Figure 82: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Share Analysis (%)<br />
By <strong>Disease</strong> Indication, 2016–2024<br />
Figure 83: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Y-o-Y Growth (%)<br />
By <strong>Disease</strong> Indication, 2016–2024<br />
Figure 84: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Share Analysis (%)<br />
By Country, 2016–2024<br />
Figure 85: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Y-o-Y Growth (%)<br />
By Country, 2016–2024<br />
Figure 86: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis<br />
(US$ Mn) By Brazil, 2016–2024<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 37
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Figure 87: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $<br />
Opportunity (US$ Mn) By Brazil, 2016–2024<br />
Figure 88: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis<br />
(US$ Mn) By Mexico, 2016–2024<br />
Figure 89: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $<br />
Opportunity (US$ Mn) By Mexico, 2016–2024<br />
Figure 90: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis<br />
(US$ Mn) By Argentina, 2016–2024<br />
Figure 91: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $<br />
Opportunity (US$ Mn) By Argentina, 2016–2024<br />
Figure 92: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis<br />
(US$ Mn) By Rest of Latin America, 2016–2024<br />
Figure 93: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $<br />
Opportunity (US$ Mn) By Rest of Latin America, 2016–2024<br />
Figure 94: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness<br />
Analysis, By Country, 2016–2024<br />
Figure 95: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness<br />
Analysis, By <strong>Disease</strong> Indication, 2016–2024<br />
Figure 96: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness<br />
Analysis, By Technique, 2016–2024<br />
Figure 97: Latin America <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness<br />
Analysis, By End User, 2016–2024<br />
Figure 98: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Share Analysis (%) By<br />
<strong>Disease</strong> Indication, 2016–2024<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 38
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Figure 99: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Y-o-Y Growth (%) By<br />
<strong>Disease</strong> Indication, 2016–2024<br />
Figure 100: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Share Analysis (%) By<br />
Country, 2016–2024<br />
Figure 101: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Y-o-Y Growth (%) By<br />
Country, 2016–2024<br />
Figure 102: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$<br />
Mn) By The U.K., 2016–2024<br />
Figure 103: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By The U.K., 2016–2024<br />
Figure 104: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$<br />
Mn) By Germany, 2016–2024<br />
Figure 105: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By Germany, 2016–2024<br />
Figure 106: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$<br />
Mn) By France, 2016–2024<br />
Figure 107: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By France, 2016–2024<br />
Figure 108: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$<br />
Mn) By Italy, 2016–2024<br />
Figure 109: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By Italy, 2016–2024<br />
Figure 110: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$<br />
Mn) By Spain, 2016–2024<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 39
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Figure 111: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By Spain, 2016–2024<br />
Figure 112: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$<br />
Mn) By Rest of Europe, 2016–2024<br />
Figure 113: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By Rest of Europe, 2016–2024<br />
Figure 114: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness Analysis, By<br />
Country, 2016–2024<br />
Figure 115: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness Analysis, By<br />
<strong>Disease</strong> Indication, 2016–2024<br />
Figure 116: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness Analysis, By<br />
Technique, 2016–2024<br />
Figure 117: Europe <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness Analysis, By<br />
End User, 2016–2024<br />
Figure 118: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Share Analysis (%) By<br />
<strong>Disease</strong> Indication, 2016–2024<br />
Figure 119: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Y-o-Y Growth (%) By<br />
<strong>Disease</strong> Indication, 2016–2024<br />
Figure 120: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Share Analysis (%) By<br />
Country, 2016–2024<br />
Figure 121: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Y-o-Y Growth (%) By<br />
Country, 2016–2024<br />
Figure 122: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$<br />
Mn) By China, 2016–2024<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 40
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Figure 123: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By China, 2016–2024<br />
Figure 124: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$<br />
Mn) By Japan, 2016–2024<br />
Figure 125: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By Japan, 2016–2024<br />
Figure 126: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$<br />
Mn) By India, 2016–2024<br />
Figure 127: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By India, 2016–2024<br />
Figure 128: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$<br />
Mn) By Australia & New Zealand, 2016–2024<br />
Figure 129: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By Australia & New Zealand, 2016–2024<br />
Figure 130: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$<br />
Mn) By Rest of APAC, 2016–2024<br />
Figure 131: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By Rest of APAC, 2016–2024<br />
Figure 133: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness Analysis, By<br />
<strong>Disease</strong> Indication, 2016–2024<br />
Figure 134: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness Analysis, By<br />
Technique, 2016–2024<br />
Figure 135: APAC <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness Analysis, By<br />
End User, 2016–2024<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 41
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Figure 136: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Share Analysis (%) By<br />
<strong>Disease</strong> Indication, 2016–2024<br />
Figure 137: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Y-o-Y Growth (%) By<br />
<strong>Disease</strong> Indication, 2016–2024<br />
Figure 138: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Share Analysis (%) By<br />
Country, 2016–2024<br />
Figure 139: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Y-o-Y Growth (%) By<br />
Country, 2016–2024<br />
Figure 140: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$ Mn)<br />
By GCC Countries, 2016–2024<br />
Figure 141: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By GCC Countries, 2016–2024<br />
Figure 142: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$ Mn)<br />
By South Africa, 2016–2024<br />
Figure 143: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By South Africa, 2016–2024<br />
Figure 144: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Revenue Analysis (US$ Mn)<br />
By Rest of MEA, 2016–2024<br />
Figure 145: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Absolute $ Opportunity<br />
(US$ Mn) By Rest of MEA, 2016–2024<br />
Figure 146: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness Analysis, By<br />
Country, 2016–2024<br />
Figure 147: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness Analysis, By<br />
<strong>Disease</strong> Indication, 2016–2024<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 42
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Figure 148: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness Analysis, By<br />
Technique, 2016–2024<br />
Figure 149: MEA <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostic</strong>s Market Attractiveness Analysis, By<br />
End User, 2016–2024<br />
Figure 150: Market Share of Prominent Key Players: <strong>Infectious</strong> <strong>Disease</strong>s Market,<br />
2015<br />
For information regarding permissions, contact:<br />
Persistence Market Research<br />
90 Sate Street, Suite 700 Albany, NY 12207<br />
Tel: +1-518-618-1030<br />
Email: sales@persistencemarketresearch.com<br />
Website: http://www.persistencemarketresearch.com/<br />
media@persistencemarketresearch.com<br />
Medical Imaging Equipment Market, 2015 - 2023 Page | 43
Change language